Literature DB >> 30345947

A review of foot-and-mouth disease virus (FMDV) testing in livestock with an emphasis on the use of alternative diagnostic specimens.

Korakrit Poonsuk1, Luis Giménez-Lirola1, Jeffrey J Zimmerman1.   

Abstract

Foot-and-mouth disease virus (FMDV) remains an important pathogen of livestock more than 120 years after it was identified, with annual costs from production losses and vaccination estimated at €5.3-€17 billion (US$6.5-US$21 billion) in FMDV-endemic areas. Control and eradication are difficult because FMDV is highly contagious, genetically and antigenically diverse, infectious for a wide variety of species, able to establish subclinical carriers in ruminants, and widely geographically distributed. For early detection, sustained control, or eradication, sensitive and specific FMDV surveillance procedures compatible with high through-put testing platforms are required. At present, surveillance relies on the detection of FMDV-specific antibody or virus, most commonly in individual animal serum, vesicular fluid, or epithelial specimens. However, FMDV or antibody are also detectable in other body secretions and specimens, e.g., buccal and nasal secretions, respiratory exhalations (aerosols), mammary secretions, urine, feces, and environmental samples. These alternative specimens offer non-invasive diagnostic alternatives to individual animal sampling and the potential for more efficient, responsive, and cost-effective surveillance. Herein we review FMDV testing methods for contemporary and alternative diagnostic specimens and their application to FMDV surveillance in livestock (cattle, swine, sheep, and goats).

Entities:  

Keywords:  Diagnosis; FMDV; foot-and-mouth disease virus; review; specimen; surveillance

Mesh:

Substances:

Year:  2018        PMID: 30345947     DOI: 10.1017/S1466252318000063

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  7 in total

1.  Recombinant T7 Phage with FMDV AKT-III Strain VP1 Protein is a Potential FMDV Vaccine.

Authors:  Peng Wu; Xinyue Yin; Qingqing Liu; Wenxing Wu; Chuangfu Chen
Journal:  Biotechnol Lett       Date:  2020-09-29       Impact factor: 2.461

2.  Air pollution and airborne infection with mycobacterial bioaerosols: a potential attribution of soot.

Authors:  J Noda; S Tomizawa; K Takahashi; K Morimoto; S Mitarai
Journal:  Int J Environ Sci Technol (Tehran)       Date:  2021-02-21       Impact factor: 2.860

Review 3.  The Swine IFN System in Viral Infections: Major Advances and Translational Prospects.

Authors:  Elisabetta Razzuoli; Federico Armando; Livia De Paolis; Malgorzata Ciurkiewicz; Massimo Amadori
Journal:  Pathogens       Date:  2022-01-27

4.  Global Phosphoproteomics Analysis of IBRS-2 Cells Infected With Senecavirus A.

Authors:  Jieyi Li; Zhongwang Zhang; Jianliang Lv; Zhongyuan Ma; Li Pan; Yongguang Zhang
Journal:  Front Microbiol       Date:  2022-01-26       Impact factor: 5.640

5.  Component Identification and Analysis of Vesicular Fluid From Swine Infected by Foot-and-Mouth Disease Virus.

Authors:  Ting Zhang; Bingzhou Lu; Bo Yang; Dajun Zhang; Xijuan Shi; Chaochao Shen; Huimei Cui; Xingguo Yuan; Dengshuai Zhao; Jinke Yang; Yu Hao; Xuehui Chen; Xiangtao Liu; Keshan Zhang; Haixue Zheng
Journal:  Front Vet Sci       Date:  2022-03-17

6.  Infectious dose of Senecavirus A in market weight and neonatal pigs.

Authors:  Alexandra Buckley; Kelly Lager
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

7.  A Naked-Eye Visual Reverse Transcription Loop-Mediated Isothermal Amplification with Sharp Color Changes for Potential Pen-Side Test of Foot-and-Mouth Disease Virus.

Authors:  Jie Zhang; Qian Hou; Weimin Ma; Danian Chen; Weibing Zhang; Ashenafi Kiros Wubshet; Yaozhong Ding; Miaomiao Li; Qian Li; Jiao Chen; Junfei Dai; Guohua Wu; Ziteng Zhang; Alexei D Zaberezhny; Zygmunt Pejsak; Kazimierz Tarasiuk; Muhammad Umar Zafar Khan; Yang Wang; Jijun He; Yongsheng Liu
Journal:  Viruses       Date:  2022-09-07       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.